ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BMS’ Opdivo combo gets FDA approval for malignant pleural mesothelioma
October 10, 2020The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb (BMS)’s Opdivo (nivolumab) plus Yervoy (ipilimumab) for treating adults with unresectable malignant pleural mesothelioma (MPM). -
Anticancer drug nintedanib found to be effective against malignant pleural mesothelioma
May 22, 2018Researchers have found that nintedanib shows promising effectiveness in halting the growth of human malignant pleural mesothelioma in preclinical models.
Pharma Sources Insight January 2025
